206 related articles for article (PubMed ID: 25148170)
21. Assessing the Effect of Various Blood Glucose Levels on
Sarikaya I; Sarikaya A; Sharma P
J Nucl Med Technol; 2019 Dec; 47(4):313-318. PubMed ID: 31182660
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
23. FDG PET/CT of the non-malignant liver in an increasingly obese world population.
Keramida G; Peters AM
Clin Physiol Funct Imaging; 2020 Sep; 40(5):304-319. PubMed ID: 32529712
[TBL] [Abstract][Full Text] [Related]
24. Fasting hepatic glucose uptake is higher in men than women.
Keramida G; Peters AM
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28583989
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
26. Effects of varying serum glucose levels on 18F-FDG biodistribution.
Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
[TBL] [Abstract][Full Text] [Related]
27. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
28. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
Demeure F; Hanin FX; Bol A; Vincent MF; Pouleur AC; Gerber B; Pasquet A; Jamar F; Vanoverschelde JL; Vancraeynest D
J Nucl Med; 2014 Oct; 55(10):1629-35. PubMed ID: 25082852
[TBL] [Abstract][Full Text] [Related]
30. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
32. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET.
Lin CY; Ding HJ; Lin T; Lin CC; Kuo TH; Kao CH
Clin Imaging; 2010; 34(2):109-12. PubMed ID: 20189073
[TBL] [Abstract][Full Text] [Related]
33. Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer.
An YS; Sheen SS; Oh YJ; Hwang SC; Yoon JK
Ann Nucl Med; 2007 Dec; 21(10):585-92. PubMed ID: 18092135
[TBL] [Abstract][Full Text] [Related]
34. Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas.
Wong CY; Thie J; Parling-Lynch KJ; Zakalik D; Margolis JH; Gaskill M; Hill J; Qing F; Fink-Bennett D; Nagle C
J Nucl Med; 2005 Oct; 46(10):1659-63. PubMed ID: 16204716
[TBL] [Abstract][Full Text] [Related]
35. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
36. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
[TBL] [Abstract][Full Text] [Related]
37. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
38. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
Kim SJ; Chang S
Oncol Res Treat; 2015; 38(11):577-85. PubMed ID: 26599271
[TBL] [Abstract][Full Text] [Related]
39. Effect of hyperglycemia on brain and liver
Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
